title: Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations.
authors.affiliation: Service d'Hématologie, Unité AJA, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.|Université Paris VI, 4 place Jussieu, 75005 Paris, France.
authors.forename: Catherine
authors.initials: C
authors.lastname: Poirot
authors.affiliation: Service d'Hématologie, Unité AJA, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Dhedin
authors.affiliation: Service d'Hématologie-Oncologie, Hôpital Saint Louis, 1 avenue Claude Vellefaux, 75010 Paris, France.
authors.forename: Pauline
authors.initials: P
authors.lastname: Brice
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D005298:Fertility; D059247:Fertility Preservation / Q000379:methods; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007246:Infertility / Q000209:etiology; D054315:Oocyte Retrieval; D009865:Oocytes / Q000187:drug effects; D014747:Vinblastine / Q000009:adverse effects
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin
keywords: ABVD; Hodgkin lymphoma; fertility preservation